Merck Profile

USD 0.3  0.53%

Acquisition by Mcglynn Margaret G of 40800 shares of Merck subject to Rule 16b-3

Merck Co Inc insider trading alert for grant of employee stock option 20090424 (right to buy) by Mcglynn Margaret G, President MV & ID, on February 18, 2018. This event was filed by Merck Co Inc with SEC on 2009-04-27. Statement of changes in beneficial ownership - SEC Form 4 [view details]   

Merck Summary

Being in one of the most regulated sectors, Merck is one of the names in big pharma and distributes many different types of medications and drugs. This industry is a go big or go home industry as that research and development costs large sums of money to complete, and if they drug does not get FDA approval, all of that work was for not. Also, it is important to keep an eye on the medical marijuana market as this is a direct threat to companies that produce medications. [more]
Merck Co Inc (MRK) is traded on New York Stock Exchange in USA. It is located in NEW JERSEY, U.S.A and employs 69,000 people. Merck is listed under Pharmaceutical Products category by Fama And French industry classification.The company currently falls under 'Mega-Cap' category with total capitalization of 151.02 B. Merck Co Inc runs under Healthcare sector within Pharmaceuticals And Biosciences industry. This company has 2.72 B outstanding shares of which 20.33 M shares are now shorted by investors with about 1.47 days to cover shorted positions. MERCK CO INC has about 11.19 B in cash with 6.06 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.11.
Check Merck Probability Of Bankruptcy

Ownership Allocation (%)

Top Holders

Major Institutional Holders

InstituionSecurity TypeTotal SharesValue
Vanguard Group IncCommon Shares197.5 M11.1 B
Blackrock IncCommon Shares184.8 M10.4 B
View Merck Diagnostics

Selected Merck Co Inc Income Statement Over Time

Consolidated Income    Cost of Revenue    Earning Before Interest and Taxes EBIT    

Key Fundamentals

Merck Against Markets

Risk Adjusted
Performance Score (0 to 100)
Chance of
Financial Distress (0 to 100%)
< 29% 
Equity ratings for Merck Co Inc are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
It operates in four segments Pharmaceutical, Animal Health, Healthcare Services, and Alliances. The company was founded in 1891 and is headquartered in Kenilworth, New Jersey. Merck operates under Drug Manufacturers - Major classification in USA and traded on New York Stock Exchange exchange. It employs 69000 people. more
Fama & French Pharmaceutical Products
Pharmaceutical Products
Fama & French Classification
NameMerck Co Inc
Chairman, CEO and PresKenneth FrazierAll Leadership
Analyst Consensus
Piotroski F Score
Macroaxis Advice
Bond Rating
Healthcare, Pharmaceuticals And Biosciences
InstrumentUSA Stock Stocks Directory
RegionNorth America
Business Address2000 Galloping Hill Road
Foreign Associates
ExchangeNew York Stock Exchange
CIK Number00310158.0
IndustryPharmaceuticals And Biosciences
Contact Number908 740 4000
Related EntitySGP
CurrencyUSD - US Dollar

Current Sentiment - MRK

Merck Co Inc Investor Sentiment
Predominant part of Macroaxis users are now bullish on Merck Co Inc. What is your trading attitude regarding investing in Merck Co Inc? Are you bullish or bearish?
98% Bullish
2% Bearish
Skip  Hide


Merck Analyst Recommendations
Target PriceAdvice# of Analysts
Merck Co Inc current and past analyst recommendations published by number of research institutions as well as average analyst consensus
Merck Analyst Advice  


Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Investing Ideas  


Merck Earnings Estimates
EPSEstimate Date
Quarterly Estimate0.82May 2, 2017
Merck Co Inc normalized analysts earnings estimates for actual as well as projected forward EPS values taken as an average expert opinion over time
Earnings Estimate  


Merck Corporate Directors
Thomas Glocer Independent Director
Craig Thompson Independent Director
Rochelle Lazarus Independent Director